BioArctic AB (FRA:B9A) Cyclically Adjusted Revenue per Share: €0.55 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:B9A BioArctic AB FRA:B9A
60 GF Score
Price €30.00
! 2 Warning Signs
View Full Analysis

What is BioArctic AB Cyclically Adjusted Revenue per Share?

BioArctic AB FRA:B9A +3.73% 60 Cyclically Adjusted Revenue per Share is €0.55 as of Mar. 2026. GuruFocus rates FRA:B9A with a GF Score™ of 60/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

BioArctic AB's adjusted revenue per share for the three months ended in Mar. 2026 was €0.457. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.55 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-02), BioArctic AB's current stock price is €30.00. BioArctic AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €0.55. BioArctic AB's Cyclically Adjusted PS Ratio of today is 54.55.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of BioArctic AB was 57.87. The lowest was 49.16. And the median was 52.32.


BioArctic AB  (FRA:B9A) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BioArctic AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=30.00/0.55
=54.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of BioArctic AB was 57.87. The lowest was 49.16. And the median was 52.32.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


BioArctic AB Cyclically Adjusted Revenue per Share Related Terms


BioArctic AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for BioArctic AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioArctic AB Cyclically Adjusted Revenue per Share Chart

BioArctic AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioArctic AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.55

FRA:B9A vs VRTX, REGN, RVMD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, BioArctic AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioArctic AB Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BioArctic AB's Cyclically Adjusted PS Ratio falls into.


FRA:B9A
60GF Score
BioArctic AB FRA:B9A
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioArctic AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioArctic AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.457/133.5600*133.5600
=0.457

Current CPI (Mar. 2026) = 133.5600.

BioArctic AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 0.000 100.276 0.000
201609 0.001 101.138 0.001
201612 0.110 102.022 0.144
201703 0.031 102.022 0.041
201706 0.037 102.752 0.048
201709 0.037 103.279 0.048
201712 0.058 103.793 0.075
201803 0.060 103.962 0.077
201806 0.060 104.875 0.076
201809 0.102 105.679 0.129
201812 0.560 105.912 0.706
201903 0.069 105.886 0.087
201906 0.183 106.742 0.229
201909 0.022 107.214 0.027
201912 0.029 107.766 0.036
202003 0.038 106.563 0.048
202006 0.008 107.498 0.010
202009 0.011 107.635 0.014
202012 0.009 108.296 0.011
202103 0.008 108.360 0.010
202106 0.008 108.928 0.010
202109 0.004 110.338 0.005
202112 0.005 112.486 0.006
202203 0.004 114.825 0.005
202206 0.005 118.384 0.006
202209 0.227 122.296 0.248
202212 0.002 126.365 0.002
202303 0.395 127.042 0.415
202306 0.003 129.407 0.003
202309 0.199 130.224 0.204
202312 0.011 131.912 0.011
202403 0.030 132.205 0.030
202406 0.050 132.716 0.050
202409 0.076 132.304 0.077
202412 0.100 132.987 0.100
202503 1.329 132.825 1.336
202506 0.402 133.699 0.402
202509 0.137 133.480 0.137
202512 0.191 133.390 0.191
202603 0.457 133.560 0.457

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.55 mean?
BioArctic AB (FRA:B9A) has a Cyclically Adjusted Revenue per Share of €0.55 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on BioArctic AB and its competitors.
Is BioArctic AB's Cyclically Adjusted Revenue per Share too high?
BioArctic AB's current Cyclically Adjusted Revenue per Share is €0.55. Overall, BioArctic AB has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does BioArctic AB's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
BioArctic AB's Cyclically Adjusted Revenue per Share of €0.55 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on BioArctic AB and its competitors. BioArctic AB's current Cyclically Adjusted Revenue per Share is €0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioArctic AB stock overvalued right now?
BioArctic AB (FRA:B9A) has a current Cyclically Adjusted Revenue per Share of €0.55. The current Cyclically Adjusted Revenue per Share is €0.55. BioArctic AB's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For BioArctic AB (FRA:B9A), the current Cyclically Adjusted Revenue per Share is €0.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
60GF Score

Get the complete analysis for FRA:B9A

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€30.00
Price